• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Gilead Sciences`s Yeytuo Receives Approval in Europe

    EMA

    Gilead Sciences`s Hepcludex Receives Approval in Canada

    FDA

    Gilead Sciences` Sunlenca (lenacapavir) Approved In Europe

    EMA

    Gilead`s Sunlenca (Lenacapavir) Receives Approval in Europe

    EMA

    Gilead`s Trodelvy (sacituzumab govitecan) gets Approval in Europe

    EMA

    Gilead Sciences` Trodelvy (sacituzumab govitecan) Receives Approval in Europe

    EMA

    Gilead Sciences`s Jyseleca (Filgotinib) Receives Approval In Europe

    EMA

    Gilead Sciences Ireland UC Jyseleca (Filgotinib) Receives Approval in Europe

    EMA

    Gilead Sciences Ireland`s Generic Veklury(Remdesivir)Receives Approval in Europe

    EMA

    Gilead` Odefsey(emtricitabine / rilpivirine / tenofovir alafenamide)Approved EU

    EMA

    Gilead Sciences` Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) Receives Approves in Europe

    EMA

    Gilead`s Vosevi (sofosbuvir/velpatasvir/voxilaprevi) Receives Approval In Europe

    EMA

    Gilead Sciences Gets EU Nod For Vemlidy

    EMA

    Gilead Sciences (Cobicistat; Elvitegravir; Emtricitabine; Tenofovir Alafenamide Fumarate) Approved In US

    FDA

    Gilead`s Epclusa Approved in US for Hepatitis C Treatment

    FDA

    Gilead Sciences` Epclusa (sofosbuvir / velpatasvir) receive market authorisation in EU for Hepatitis C, Chronic

    EMA

    Gilead Sciences` Odefsey receives market authorisation in EU for HIV Infections

    EMA

    Gilead`s Descovy (Emtricitabine;Tenofovir Alafenamide)approved in US for HIV-1

    FDA

    Gilead Sciences`s Odefsey approved in US for treatment of HIV

    FDA

    Gilead`s Descovy (emtricitabine / tenofovir alafenamide) receives marketing authorisation in EU for treatment of HIV infection

    EMA

    Gilead`s Viread (Tenofovir Disoproxil Fumarate) Receives Supplemental Approval in USA For HIV

    FDA

    Chugai, Gilead Get Japanese Approval For Additional Indication Of Antiviral Drug Copegus

    BIOSPECTRUM

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.